tiprankstipranks
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
US Market

Arrowhead Pharmaceuticals (ARWR) Ownership - Who Owns Arrowhead Pharmaceuticals?

Compare
1,492 Followers

Arrowhead Pharmaceuticals (ARWR) Ownership Overview

4.52%19.00%24.39%28.27%23.81%
24.39% Other Institutional Investors
28.27% ETFs
23.81% Public Companies and Individual Investors
The ownership structure of Arrowhead Pharmaceuticals (ARWR) stock is a mix of institutional, retail, and individual investors. Approximately 71.66% of the company’s stock is owned by Institutional Investors, 4.52% is owned by Insiders, and 23.81% is owned by Public Companies and Individual Investors.
The ownership structure of Arrowhead Pharmaceuticals (ARWR) stock is a mix of institutional, retail, and individual investors. Approximately 43.39% of the company’s stock is owned by Institutional Investors, 4.52% is owned by Insiders, and 28.27% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 07, 2025
xxxxxxxxxxxxx
$196900
Apr 03, 2024
James C Hamilton
Chief Discovery/trans Medicine
xxxxxxxxxxxxx
$168180
Mar 20, 2024
Hongbo Lu
Director
xxxxxxxxxxxxx
$82990
Mar 08, 2024
xxxxxxxxxxxxx
$1407600

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$2687253

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
18,426,423Institution14.61%367,607,139
11,759,787Institution9.33%234,607,751
10,177,542Institution8.07%203,041,963
5,232,000Institution4.15%104,378,400
3,773,802Insider2.99%75,287,350
3,623,428Institution2.87%72,287,389
1,561,941Institution1.24%31,160,723
1,301,965Institution1.03%25,974,202
1,249,556Institution0.99%24,928,642
1,222,835Institution0.97%24,395,558

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
10,177,542Institution8.07%203,041,963
1,561,941Institution1.24%31,160,723
1,301,965Institution1.03%25,974,202
1,249,556Institution0.99%24,928,642
1,222,835Institution0.97%24,395,558
1,109,494Institution0.88%22,134,405
807,099Institution0.64%16,101,625
682,597Institution0.54%13,617,810
661,739Institution0.52%13,201,693
548,851Institution0.44%10,949,577

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
7,946,433Institution6.30%151,856,335
3,663,147Institution2.90%68,867,164
3,364,205Institution2.67%79,798,943
3,204,707Institution2.54%63,933,905
3,010,327Institution2.39%56,594,148
1,892,413Institution1.50%35,577,364
1,710,177Institution1.36%32,151,328
1,450,891Institution1.15%27,726,527
1,127,040Institution0.89%21,537,734
1,065,342Institution0.84%21,253,573

FAQ

Who Owns Arrowhead Pharmaceuticals (ARWR)?
According to the latest TipRanks data, approximately 24.39% of the company's stock is held by institutional investors, 4.52% is held by insiders, and 23.81% is held by retail investors.
    What percentage of Arrowhead Pharmaceuticals (ARWR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 24.39% of Arrowhead Pharmaceuticals (ARWR) stock is held by institutional investors.
      What percentage of Arrowhead Pharmaceuticals (ARWR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 23.81% of Arrowhead Pharmaceuticals (ARWR) stock is held by retail investors.
        Who owns the most shares of Arrowhead Pharmaceuticals (ARWR)?
        iShares owns the most shares of Arrowhead Pharmaceuticals (ARWR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis